NEW YORK, NY / ACCESSWIRE / November 27, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sona Nanotech Inc. ("Sona" or "the Company") (OTCQB:SNANF). Investors who purchased Sona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/snanf.
The investigation concerns whether Sona and certain of its officers and/or directors have violated federal securities laws.
On October 29, 2020, Sona announced that the Food and Drug Administration ("FDA") denied its request for an emergency use authorization for the marketing of its rapid COVID-19 antigen test in the United States. Following this news, Sona stock dropped 48%, and closed at $3.00 per share that same day. Then on November 25, 2020, Sona revealed its withdrawal of "an Interim Order authorization from Health Canada for the marketing of its rapid, COVID-19 antigen test in order to obtain more clinical data to augment its submission." Following this news, Sona stock dropped over 67% to close at $0.74 per share that same day.
If you are aware of any facts relating to this investigation, or purchased Sona shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/snanf. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com:
https://www.accesswire.com/618540/Bronstein-Gewirtz-Grossman-LLC-Notifies-Investors-of-Sona-Nanotech-Inc-SNANF-Investigation
